Draft Pandemic Accord Has IP Waivers, Pathogen Sharing Perks
The draft pandemic accord, which was sent to member states of the World Health Organisation by the Intergovernmental Negotiating Body recently, includes several important elements. One of these is the provision for time-bound waivers when it comes to intellectual property- IP rights and benefits for countries sharing information about threatening pathogens. Both of these problems […]
QIAGEN receives CDSCO approval for NeuMoDx HIV-1, HBV and HCV Quant assays in India for blood-borne virus testing
QIAGEN announced that its NeuMoDx human immunodeficiency virus type 1 (HIV-1), hepatitis B virus (HBV) and hepatitis C virus (HCV) quantitative assays for blood-borne virus (BBV) testing has received Central Drugs Standard Control Organization (CDSCO) approval in India. These blood-borne virus assays are the first to be registered in India with additional NeuMoDx infectious disease […]
Identifying Warning Signs of Prescription Drug Addiction
While prescription medications are indispensable for managing various health conditions, their misuse can lead to a hazardous cycle known as prescription drug addiction. This issue poses significant risks to one’s overall health and wellness. Recognizing the signs is crucial to facilitate timely intervention and treatment. Unpacking the Concept of Prescription Drug Addiction Prescription drug addiction […]
Pharma Giants And The Curious Case of Antitrust Lawsuits
Although one must have heard of tech giants such as Microsoft, Apple, as well as Meta getting caught up in certain antitrust scandals, big pharma is no less involved when it comes to antitrust litigation. Tactics such as pay-for-delay that put off generic drugs from making an entry into the market can go on to […]
Astellas & Pfizer Settle Their Lawsuit Against Sun Pharma
As per findings pertaining to court filings, Astellas Pharma Inc. and Pfizer Inc. have gone on to reach a settlement in their lawsuit against Sun Pharmaceutical Industries Ltd. with regards to the production of a generic variant of the highly valuable prostate cancer medication, Xtandi. According to the proposed dismissal order, which was filed on […]
CPHI selects 2023 Pharma Award winners
CPHI Barcelona announces the winners of the prestigious 2023 CPHI Pharma Awards. The awards recognise outstanding achievements and contributions from the global pharma industry and supply chain across 12 wide-ranging categories. Enrico Zodio, CEO of Procos, stood out as the clear winner in one of the most coveted prizes – CEO of the Year – for […]
DuPont introduces conductive tape for use as dry electrode in biosignal monitoring
DuPont announced that it is introducing DuPont™ Liveo™ Soft Skin Conductive Tape 1-3150 – a silicone-based thermoset adhesive for electrical biosignal sensing and transfer. Combining the key benefits of silicone technology with electrically conductive properties, Liveo™ Soft Skin Conductive Tape technology is intended for use as a skin dry electrode in biosignal monitoring applications to […]
Phastar Offers Pro Bono Support to Medicines Development for Global Health
Phastar, a global specialist biometrics contract research organization (CRO), is offering pro bono support to Medicines Development for Global Health (MDGH), a not-for-profit organization developing medicines for neglected diseases primarily affecting people living in low- and middle-income countries. As part of the Phastar Cares scheme, MDGH has pro bono access to the company’s biometrics experts […]
Samsung Biologics and Kurma Partners announce strategic partnership for development and manufacturing of biologics for Kurmas portfolio companies
Samsung Biologics to provide de-risking, development, manufacturing services, and seamless transitions for biologics from early stages of development to large-scale commercialization The partnership will streamline gene to IND process to accelerate lead candidate selection and advance CMC along clinical development Multi-year collaboration expected to support sustainable growth of the biopharmaceutical industry and allow Samsung Biologics […]
Andelyn Biosciences and Purespring Therapeutics Partner to Manufacture Novel Gene Therapies for Kidney Diseases
Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Purespring Therapeutics, a biotech innovator company, to accelerate the manufacture of their gene therapies for the treatment of chronic renal diseases that are currently poorly addressed. The partnership will enable Purespring to advance and accelerate […]
